| Literature DB >> 26069421 |
Italo Mocchetti1, Alessia Bachis1, Giuseppe Esposito2, Scott R Turner3, Francesca Taraballi4, Ennio Tasciotti4, Mikell Paige5, Valeriya Avdoshina1.
Abstract
In the late stage of human immunodeficiency virus-1 (HIV) infection, a subset of individuals develops HIV associated neurocognitive disorders (HAND), which in its severe form, is characterized by motor and cognitive dysfunction. Dendritic pruning, synaptic abnormalities and neuronal apoptosis are observed in these patients. There are numerous advances in our understanding of HIV interactions with cells of the central nervous system. However, the underlying causes of neurological symptoms and pathological alterations observed in HIV positive subjects are poorly understood. Moreover, little is still known about the molecular mechanisms by which HIV induces synaptic dysfunction and degeneration. HAND resembles other common neurological diseases such as Alzheimer's and Huntington's diseases. These neurodegenerative disorders are characterized by accumulation of toxic proteins such as tau and huntingtin, respectively, which promote axonal degeneration by impairing axonal transport. Axonal degeneration precedes neuronal death. Therefore, a better understanding of the mechanisms whereby HIV triggers axonal degeneration has potential implications for developing therapeutic compounds to prevent synaptic failure in HAND. This article highlights and reviews evidence showing that neuronal accumulation of viral proteins promotes axonal damage.Entities:
Keywords: Alzheimer’s disease; HAND; HIV; axonal degeneration; brain-derived neurotrophic factor; gp120; microtubules; neurocognitive impairments
Year: 2014 PMID: 26069421 PMCID: PMC4461001
Source DB: PubMed Journal: Curr Trends Neurol ISSN: 0972-8252